Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02056301 · ClinicalTrials.gov registry record · Phase 4
A Comparison Trial Between PCA and Epidural Analgesia for Pectus Excavatum Repair
A Phase 4 study, sponsored by Baylor College of Medicine.
- Terminated
- Registry status
- Phase 4
- Development phase
- 62
- Enrollment target
NCT02056301 is a Phase 4 study that was terminated before completion, run by Baylor College of Medicine. The registered enrollment target is 62 participants.
The verdict
NCT02056301, a Phase 4 study, was terminated before completion, sponsored by Baylor College of Medicine.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 62 participants
- Enrollment target
Study Summary
The aim of this study is to compare the efficacy of epidural and IV analgesia in controlling pain in patients undergoing Nuss repair of pectus excavatum. The primary end point will be the mean pain score during postoperative days 0-4.
Interventions
- DRUG Hydromorphone
- DRUG Morphine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2012-08 |
| Est. Completion | 2019-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02056301
The ClinicalTrials.gov registry entry for NCT02056301 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Hydromorphone is the first listed.
NCT02056301 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02056301 about?
NCT02056301 is a clinical study titled "A Comparison Trial Between PCA and Epidural Analgesia for Pectus Excavatum Repair". The aim of this study is to compare the efficacy of epidural and IV analgesia in controlling pain in patients undergoing Nuss repair of pectus excavatum. The primary end point will be the mean pain score during postoperative days 0-4.
What is the current status of trial NCT02056301?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 62 participants. The study started on 2012-08. Estimated completion is 2019-10.
What interventions are being tested in trial NCT02056301?
The interventions under investigation include: Hydromorphone (DRUG), Morphine (DRUG).
Who is sponsoring clinical trial NCT02056301?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.